BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Marion Levast, Sylvie Larrat, Marie-Ange Thelu, Sandrine Nicod, Agnès Plages, Alice Cheveau, Jean-Pierre Zarski, Jean-Marie Seigneurin, Patrice Morand, Vincent Leroy. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirinJournal of Medical Virology 2010; 82(5): 747 doi: 10.1002/jmv.21695
2
Patricia M. Mulrooney-Cousins, Ranjit Chauhan, Norma D. Churchill, Tomasz I. Michalak, Aleem Siddiqui. Primary Seronegative but Molecularly Evident Hepadnaviral Infection Engages Liver and Induces Hepatocarcinoma in the Woodchuck Model of Hepatitis BPLoS Pathogens 2014; 10(8): e1004332 doi: 10.1371/journal.ppat.1004332
3
Shivali S. Joshi, Carla S. Coffin. Hepatitis B virus lymphotropism: emerging details and challengesBiotechnology and Genetic Engineering Reviews 2018; 34(1): 139 doi: 10.1080/02648725.2018.1474324
4
R. A. A. Pondé. Molecular mechanisms underlying HBsAg negativity in occult HBV infectionEuropean Journal of Clinical Microbiology & Infectious Diseases 2015; 34(9): 1709 doi: 10.1007/s10096-015-2422-x
5
Amadin A. Olotu, Adesola O. Oyelese, Lateef Salawu, Rosemary A. Audu, Azuka P. Okwuraiwe, Aaron O. Aboderin. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantationVirology Journal 2016; 13(1) doi: 10.1186/s12985-016-0533-3
6
Tomasz I. Michalak. Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis BFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00853
7
William S. Mason. Cancer Associated Viruses2012; : 531 doi: 10.1007/978-1-4614-0016-5_22
8
Assem El-Sherif, Mohamed Abou-Shady, Hany Abou-Zeid, Ahmed Elwassief, Ashraf Elbahrawy, Yoshihide Ueda, Tsutomu Chiba, Abdel-Moneim Hosney. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patientsJournal of Gastroenterology 2009; 44(4): 359 doi: 10.1007/s00535-009-0020-3
9
E-H Park, S S Koh, R Srisuttee, I-R Cho, H-J Min, B H Jhun, Y-S Lee, K L Jang, C-H Kim, R N Johnston, Y-H Chung. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cellsCancer Gene Therapy 2009; 16(5): 453 doi: 10.1038/cgt.2008.95
10
C. S. Coffin, P. M. Mulrooney-Cousins, M. G. Peters, G. van Marle, J. P. Roberts, T. I. Michalak, N. A. Terrault. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapyJournal of Viral Hepatitis 2011; 18(6): 415 doi: 10.1111/j.1365-2893.2010.01321.x
11
Georget Y. Reaiche, Marc F. Le Mire, William S. Mason, Allison R. Jilbert. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesisVirology 2010; 406(2): 286 doi: 10.1016/j.virol.2010.07.013
12
Tomasz I. Michalak, Hong Zhang, Norma D. Churchill, Torbjörn Larsson, Nils-Gunnar Johansson, Bo Öberg. Profound Antiviral Effect of Oral Administration of MIV-210 on Chronic Hepadnaviral Infection in a Woodchuck Model of Hepatitis BAntimicrobial Agents and Chemotherapy 2009; 53(9): 3803 doi: 10.1128/AAC.00263-09
13
Hui-Lan Zhu, Xu Li, Jun Li, Zhen-Hua Zhang. Genetic variation of occult hepatitis B virus infectionWorld Journal of Gastroenterology 2016; 22(13): 3531-3546 doi: 10.3748/wjg.v22.i13.3531
14
Giovanni Raimondo, Stephen Locarnini, Teresa Pollicino, Massimo Levrero, Fabien Zoulim, Anna S. Lok, Jean-Pierre Allain, Thomas Berg, Antonio Bertoletti, Maurizia Rossana Brunetto, Raffaele Bruno, Ding-Shinn Chen, Nicola Coppola, Markus Cornberg, Antonio Craxì, Maura Dandri, Vito Di Marco, Carlo Ferrari, Giovanni Battista Gaeta, Dieter Glebe, Luca G. Guidotti, Anna Kramvis, Pietro Lampertico, Chengyao Li, Jake Liang, Alfredo Marzano, Thomas I. Michalak, Jean-Michel Pawlotsky, Daniele Prati, Massimo Puoti, Didier Samuel, Vincent Soriano, Giovanni Squadrito, Camille Sureau, Christian Trepo, Man-Fung Yuen. Update of the statements on biology and clinical impact of occult hepatitis B virus infectionJournal of Hepatology 2019; 71(2): 397 doi: 10.1016/j.jhep.2019.03.034
15
Ramazan Idilman, Mutlu Arat. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantationExpert Review of Anti-infective Therapy 2011; 9(8): 641 doi: 10.1586/eri.11.79
16
S. A. Gujar, P. M. Mulrooney-Cousins, T. I. Michalak. Repeated Exposure to Trace Amounts of Woodchuck Hepadnavirus Induces Molecularly Evident Infection and Virus-Specific T Cell Response in the Absence of Serological Infection Markers and HepatitisJournal of Virology 2013; 87(2): 1035 doi: 10.1128/JVI.01363-12
17
Emilio D'Ugo, Claudio Argentini, Roberto Giuseppetti, Andrea Canitano, Stefania Catone, Maria Rapicetta. The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapiesExpert Opinion on Drug Discovery 2010; 5(12): 1153 doi: 10.1517/17460441.2010.530252
18
Birama Diarra, Abdoul Karim Ouattara, Florencia Wendkuuni Djigma, Tegwinde Rebeca Compaore, Dorcas Obiri-Yeboah, Lassina Traore, Serge Theophile Soubeiga, Prosper Bado, Justine Yara, Virginio Pietra, Paul Ouedraogo, Alain Bougouma, Rokia Sanogo, Jacques Simpore. World Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and VaccinationHepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.13789
19
Giovanni Raimondo, Gaia Caccamo, Roberto Filomia, Teresa Pollicino. Occult HBV infectionSeminars in Immunopathology 2013; 35(1): 39 doi: 10.1007/s00281-012-0327-7
20
Shashi A. Gujar, Adam K.M. Jenkins, Sonya A. MacParland, Tomasz I. Michalak. Pre-acute hepadnaviral infection is associated with activation-induced apoptotic death of lymphocytes in the woodchuck (Marmota monax) model of hepatitis BDevelopmental & Comparative Immunology 2010; 34(9): 999 doi: 10.1016/j.dci.2010.05.001
21
Ying Lu, Ya-Lin Liu, Jing-Jing Nie, Xiao-Feng Liang, Ling Yan, Fu-Zhen Wang, Xiang-Jun Zhai, Jian-Xun Liu, Feng-Cai Zhu, Zhan-Jun Chang, Jie Li, Antonio Bertoletti. Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up StudyPLOS ONE 2016; 11(11): e0166317 doi: 10.1371/journal.pone.0166317
22
Yi‐Ming Chen, Hsin‐Hua Chen, Wen‐Nan Huang, Yi‐Hsing Chen, Tsu‐Yi Hsieh, Sheng‐Shun Yang, Joung‐Liang Lan, Der‐Yuan Chen. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observationInternational Journal of Rheumatic Diseases 2019;  doi: 10.1111/1756-185X.13582
23
Paul Schmeltzer, Kenneth E. Sherman. Occult Hepatitis B: Clinical Implications and Treatment DecisionsDigestive Diseases and Sciences 2010; 55(12): 3328 doi: 10.1007/s10620-010-1413-0
24
Suda Louisirirotchanakul, Sineenart Oota, Kalayanee Khuponsarb, Wilai Chalermchan, Soisaang Phikulsod, Viroje Chongkolwatana, Tasanee Sakuldamrongpanish, Pimpun Kitpoka, Pimol Chielsilp, Srivilai Tanprasert, Thaweesak Tirawatnapong, Chantapong Wasi. Occult hepatitis B virus infection in Thai blood donorsTransfusion 2011; 51(7): 1532 doi: 10.1111/j.1537-2995.2010.03023.x
25
Yi-Ming Chen, Sheng-Shun Yang, Der-Yuan Chen. Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative reviewJournal of Microbiology, Immunology and Infection 2019; 52(1): 1 doi: 10.1016/j.jmii.2017.10.002
26
C. Pande, S. K. Sarin, S. Patra, A. Kumar, S. Mishra, S. Srivastava, K. Bhutia, E. Gupta, C. K. Mukhopadhyay, A. K. Dutta, S. S. Trivedi. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trialJournal of Viral Hepatitis 2013; : n/a doi: 10.1111/jvh.12102
27
Min-Sun Kwak, Yoon Jun Kim. Occult hepatitis B virus infectionWorld Journal of Hepatology 2014; 6(12): 860-869 doi: 10.4254/wjh.v6.i12.860
28
So Young Jang, Mi Suk Kim, Min Seok Park, Keon Myung Lee, Hwan Won Chung, Jongsik Chun, Chan Hee Lee. Designing primers from multiple sequences using matchup program to improve detection of hepatitis B virus by polymerase chain reactionThe Journal of Microbiology 2010; 48(1): 111 doi: 10.1007/s12275-009-0282-8
29
Shashi A. Gujar, Adam K. Jenkins, Clifford S. Guy, Jinguo Wang, Tomasz I. Michalak. Aberrant Lymphocyte Activation Precedes Delayed Virus-Specific T-Cell Response after both Primary Infection and Secondary Exposure to Hepadnavirus in the Woodchuck Model of Hepatitis B Virus InfectionJournal of Virology 2008; 82(14): 6992 doi: 10.1128/JVI.00661-08
30
C. S. Coffin, P. G. Stock, L. M. Dove, C. L. Berg, N. N. Nissen, M. P. Curry, M. Ragni, F. G. Regenstein, K. E. Sherman, M. E. Roland, N. A. Terrault. Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant RecipientsAmerican Journal of Transplantation 2010; 10(5): 1268 doi: 10.1111/j.1600-6143.2010.03070.x
31
Man-Fung Yuen. Hepatitis B Virus and Liver Disease2018; : 297 doi: 10.1007/978-981-10-4843-2_15
32
Michael Nassal. Hepatitis B viruses: Reverse transcription a different wayVirus Research 2008; 134(1-2): 235 doi: 10.1016/j.virusres.2007.12.024
33
Mehdi Zobeiri. Occult Hepatitis B: Clinical Viewpoint and ManagementHepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/259148
34
Giovanni Raimondo, Teresa Pollicino. Hepatitis B Virus in Human DiseasesMolecular and Translational Medicine 2016; : 277 doi: 10.1007/978-3-319-22330-8_13
35
IL-RAE CHO, MYUNGJU OH, SANG SEOK KOH, WARAPORN MALILAS, RATAKORN SRISUTTEE, BYUNG HAK JHUN, SANDRA PELLEGRINI, SERGE Y. FUCHS, YOUNG-HWA CHUNG. Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptorInternational Journal of Molecular Medicine 2012; 29(4): 581 doi: 10.3892/ijmm.2012.879
36
R. Cassini, M. S. De Mitri, D. Gibellini, L. Urbinati, S. Bagaglio, G. Morsica, M. Domenicali, G. Verucchi, M. Bernardi. A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infectionJournal of Viral Hepatitis 2013; 20(1): 42 doi: 10.1111/j.1365-2893.2012.01623.x
37
YuQiong Li, Hui Wang, DaPeng Li, JingYi Hu, Hao Wang, DongXun Zhou, QiaoMei Li, XiaoLan Jiang, HuaBang Zhou, HePing Hu. Occult Hepatitis B Virus Infection in Chinese Cryptogenic Intrahepatic Cholangiocarcinoma Patient PopulationJournal of Clinical Gastroenterology 2014; 48(10): 878 doi: 10.1097/MCG.0000000000000058
38
Sang Hee Song, Seong Gyu Hwang. Occult Hepatitis B Virus Infection: Transmission and ReactivationThe Korean Journal of Gastroenterology 2013; 62(3): 148 doi: 10.4166/kjg.2013.62.3.148
39
Francisca Sosa-Jurado, Nora Hilda Rosas-Murrieta, Belinda Guzman-Flores, Cintia Perez Zempoaltecalt, Ana Patricia Sanchez Torres, Leticia Ramirez Rosete, Maribel Bernal-Soto, Luis Marquez-Dominguez, Daniel Melendez-Mena, Miguel Angel Mendoza Torres, Maria Teresa Lopez Delgado, Julio Reyes-Leyva, Veronica Vallejo-Ruiz, Gerardo Santos-Lopez. Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNAHepatitis Monthly 2016; 16(6) doi: 10.5812/hepatmon.36942
40
Giovanni Raimondo, Jean-Pierre Allain, Maurizia R. Brunetto, Marie-Annick Buendia, Ding-Shinn Chen, Massimo Colombo, Antonio Craxì, Francesco Donato, Carlo Ferrari, Giovanni B. Gaeta, Wolfram H. Gerlich, Massimo Levrero, Stephen Locarnini, Thomas Michalak, Mario U. Mondelli, Jean-Michel Pawlotsky, Teresa Pollicino, Daniele Prati, Massimo Puoti, Didier Samuel, Daniel Shouval, Antonina Smedile, Giovanni Squadrito, Christian Trépo, Erica Villa, Hans Will, Alessandro R. Zanetti, Fabien Zoulim. Statements from the Taormina expert meeting on occult hepatitis B virus infectionJournal of Hepatology 2008; 49(4): 652 doi: 10.1016/j.jhep.2008.07.014
41
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatmentJournal of Viral Hepatitis 2016; 23(12): 1027 doi: 10.1111/jvh.12583
42
Shashi A. Gujar, Tomasz I. Michalak. Primary Occult Hepadnavirus Infection Induces Virus-Specific T-Cell and Aberrant Cytokine Responses in the Absence of Antiviral Antibody Reactivity in the Woodchuck Model of Hepatitis B Virus InfectionJournal of Virology 2009; 83(8): 3861 doi: 10.1128/JVI.02521-08
43
Ying-Hui Shi, Chang-He Shi. Molecular characteristics and stages of chronic hepatitis B virus infectionWorld Journal of Gastroenterology 2009; 15(25): 3099-3105 doi: 10.3748/wjg.15.3099
44
Mitra Ranjbar, Masoumeh Dadkhah, Farah Bokharaei Salim, Marzieh Daneshbodi, Shokoufeh Savaj, Hossein Keyvani. The Prevalence of Occult HBV Infection Among Hemodialysis Patients of Tehran, IranModern Care Journal 2017; 14(4) doi: 10.5812/modernc.65546
45
Maria Stella De Mitri, Romina Cassini, Mauro Bernardi. Hepatitis B virus-related hepatocarcinogenesis: Molecular oncogenic potential of clear or occult infectionsEuropean Journal of Cancer 2010; 46(12): 2178 doi: 10.1016/j.ejca.2010.03.034
46
Peter B Sugden, Barbara Cameron, Rowena Bull, Peter A White, Andrew R Lloyd. Occult infection with hepatitis C virus: friend or foe?Immunology & Cell Biology 2012; 90(8): 763 doi: 10.1038/icb.2012.20
47
Vicente Carreño*, Javier Bartolomé, Inmaculada Castillo, Juan Antonio Quiroga. Occult hepatitis B virus and hepatitis C virus infectionsReviews in Medical Virology 2008; 18(3): 139 doi: 10.1002/rmv.569